https://www.marketscreener.com/quote/stock/KALVISTA-PHARMACEUTICALS--32018912/news/KalVista-meets-main-goals-in-late-stage-trial-for-genetic-disease-45939376/?utm_source=telegram&utm_medium=social&utm_campaign=share